David S. Lirenman

1.0k total citations
32 papers, 645 citations indexed

About

David S. Lirenman is a scholar working on Pediatrics, Perinatology and Child Health, Nephrology and Molecular Biology. According to data from OpenAlex, David S. Lirenman has authored 32 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pediatrics, Perinatology and Child Health, 10 papers in Nephrology and 7 papers in Molecular Biology. Recurrent topics in David S. Lirenman's work include Pediatric Urology and Nephrology Studies (6 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Renal Diseases and Glomerulopathies (5 papers). David S. Lirenman is often cited by papers focused on Pediatric Urology and Nephrology Studies (6 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Renal Diseases and Glomerulopathies (5 papers). David S. Lirenman collaborates with scholars based in Canada, United States and Tunisia. David S. Lirenman's co-authors include Paul J.D. Winyard, R. A. Risdon, Alex B. Magil, Patricia Hardman, Jeroen Nauta, Adrian S. Woolf, Virginia Sams, James E. Carter, Angus Rae and Roger A.L. Sutton and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, PEDIATRICS and Kidney International.

In The Last Decade

David S. Lirenman

31 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David S. Lirenman Canada 14 234 165 123 122 120 32 645
G Rizzoni Italy 16 301 1.3× 153 0.9× 75 0.6× 181 1.5× 125 1.0× 32 758
Jackson Joe Yium United States 12 207 0.9× 134 0.8× 39 0.3× 148 1.2× 98 0.8× 21 674
Thierry Schurmans Belgium 11 266 1.1× 80 0.5× 60 0.5× 108 0.9× 68 0.6× 19 479
İlmay Bilge Türkiye 17 448 1.9× 164 1.0× 113 0.9× 222 1.8× 275 2.3× 54 999
Wacharee Seeherunvong United States 17 353 1.5× 110 0.7× 111 0.9× 131 1.1× 271 2.3× 34 767
Kay Latta Germany 17 324 1.4× 213 1.3× 49 0.4× 346 2.8× 222 1.9× 51 1.0k
Shashi Nagaraj United States 11 244 1.0× 84 0.5× 26 0.2× 137 1.1× 98 0.8× 23 530
Sônia K. Nishida Brazil 17 254 1.1× 123 0.7× 99 0.8× 72 0.6× 85 0.7× 42 669
Kishore Phadke India 11 302 1.3× 95 0.6× 52 0.4× 58 0.5× 90 0.8× 25 498
Scott J. Schurman United States 13 58 0.2× 109 0.7× 44 0.4× 159 1.3× 89 0.7× 26 530

Countries citing papers authored by David S. Lirenman

Since Specialization
Citations

This map shows the geographic impact of David S. Lirenman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Lirenman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Lirenman more than expected).

Fields of papers citing papers by David S. Lirenman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Lirenman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Lirenman. The network helps show where David S. Lirenman may publish in the future.

Co-authorship network of co-authors of David S. Lirenman

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Lirenman. A scholar is included among the top collaborators of David S. Lirenman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Lirenman. David S. Lirenman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsuda‐Abedini, Mina, R. Morrison Hurley, Douglas G. Matsell, et al.. (2008). Outcome of kidney transplantation in Canadian Aboriginal children in the province of British Columbia. Pediatric Transplantation. 13(7). 856–860. 13 indexed citations
2.
Schachter, Asher D., Mark R. Benfield, Robert Wyatt, et al.. (2006). Sirolimus pharmacokinetics in pediatric renal transplant recipients receiving calcineurin inhibitor co‐therapy. Pediatric Transplantation. 10(8). 914–919. 30 indexed citations
3.
Primmett, D. R. N., Colin T. White, David S. Lirenman, et al.. (2005). Limited sampling strategy for cyclosporine (Neoral®) area under the curve monitoring in pediatric kidney transplant recipients. Pediatric Transplantation. 9(5). 566–573. 6 indexed citations
4.
White, Marc, et al.. (2004). Randomized trial of problem-based versus didactic seminars for disseminating evidence-based guidelines on asthma management to primary care physicians. Journal of Continuing Education in the Health Professions. 24(4). 237–243. 44 indexed citations
5.
Winters, Marinus, R. Morrison Hurley, & David S. Lirenman. (2002). ANCA-positive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil. Pediatric Nephrology. 17(4). 257–260. 14 indexed citations
6.
Virji, Mumtaz, James E. Carter, & David S. Lirenman. (2001). Single‐center experience with mycophenolate mofetil in pediatric renal transplant recipients. Pediatric Transplantation. 5(4). 293–296. 16 indexed citations
7.
Rupps, Rosemarie, David S. Lirenman, Margot I. Van Allen, et al.. (2001). Renal-coloboma syndrome: Prenatal detection and clinical spectrum in a large family. American Journal of Medical Genetics. 99(2). 137–141. 29 indexed citations
8.
Sherbotie, Joseph R., Timothy E. Bunchman, M. Broyer, et al.. (1999). MYCOPHENOLATE MOFETIL (MMF) ORAL SUSPENSION IN PEDIATRIC RENAL TRANSPLANTATION. Transplantation. 67(7). S125–S125. 2 indexed citations
9.
Werner, H., David Wensley, David S. Lirenman, & Jacques G. LeBlanc. (1997). Peritoneal dialysis in children after cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery. 113(1). 64–70. 60 indexed citations
10.
Winyard, Paul J.D., Jeroen Nauta, David S. Lirenman, et al.. (1996). Deregulation of cell survival in cystic and dysplastic renal development. Kidney International. 49(1). 135–146. 125 indexed citations
11.
Al‐Eisa, Amal, James E. Carter, David S. Lirenman, & Alex B. Magil. (1996). Childhood IgM Nephropathy: Comparison with Minimal Change Disease. ˜The œNephron journals/Nephron journals. 72(1). 37–43. 30 indexed citations
12.
AbdelWareth, Laila, et al.. (1995). Spurious rise in total carbon dioxide and chloride with negative anion gap after cystogram. Pediatric Nephrology. 9(3). 348–350. 2 indexed citations
13.
Keown, Paul, David S. Lirenman, David Landsberg, et al.. (1991). Use of cyclosporine in pediatric transplantation: Immunology, pharmacology and therapeutic implications. Clinical Transplantation. 5(2pt2). 181–185. 4 indexed citations
14.
Robinson, Joan, Peter N. Malleson, David S. Lirenman, & James Carter. (1990). Nephrotic Syndrome Associated With Nonsteroidal Anti-inflammatory Drug Use in Two Children. PEDIATRICS. 85(5). 844–847. 13 indexed citations
15.
Magil, Alex B., et al.. (1988). Prognostic factors in diffuse proliferative lupus glomerulonephritis. Kidney International. 34(4). 511–517. 74 indexed citations
16.
Magil, Alex B., et al.. (1984). Diffuse Proliferative Lupus Glomerulonephritis. Medicine. 63(4). 210–220. 35 indexed citations
17.
Steele, Brian T. & David S. Lirenman. (1979). Isotope Effect on Confinement in DT Plasmas. PubMed Central. 121(3). 142–8. 2 indexed citations
18.
Prior, Jerilynn C., et al.. (1979). Experience with 1,25-dihydroxycholecalciferol therapy in undergoing hemodialysis patients with progressive vitamin D2-treated osteodystrophy. The American Journal of Medicine. 67(4). 583–589. 20 indexed citations
19.
Cole, David E.C. & David S. Lirenman. (1978). Role of albumin-enriched peritoneal dialysate in acute copper poisoning. The Journal of Pediatrics. 92(6). 955–957. 10 indexed citations
20.
Lirenman, David S., et al.. (1973). Long-Term Use of Trimethoprim-Sulfamethoxazole in Children with Meningomyeloceles and Recurrent Urinary Tract Infections. The Journal of Infectious Diseases. 128(Supplement 3). S636–S640. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Rizzoni Breakdown of academic impact, for papers by Jackson Joe Yium Breakdown of academic impact, for papers by Thierry Schurmans Breakdown of academic impact, for papers by İlmay Bilge Breakdown of academic impact, for papers by Wacharee Seeherunvong Breakdown of academic impact, for papers by Kay Latta Breakdown of academic impact, for papers by Shashi Nagaraj Breakdown of academic impact, for papers by Sônia K. Nishida Breakdown of academic impact, for papers by Kishore Phadke Breakdown of academic impact, for papers by Scott J. Schurman
Rankless by CCL
2026